Judge Hands Pfizer A Mixed Bag In Celebrex Case

Law360, New York (July 6, 2007, 12:00 AM EDT) -- Marking both good and bad news for Pfizer Inc., the judge overseeing the massive products liability litigation over anti-inflammatory pain medications Celebrex and Bextra has opted to let numerous claims stand against the pharmaceutical giant while tossing a slew of others.

On Thursday, U.S. District Judge Charles R. Breyer partially rejected Pfizer's request to bounce a bunch of claims sought by various third-party payor plaintiffs from the multidistrict, antitrust litigation currently playing out in the U.S. District Court for the Northern District of California.

“Defendants’ motion...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.